Glucose control in the ICU: Is there a time for more ambitious targets again?

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F14%3A10286842" target="_blank" >RIV/00216208:11110/14:10286842 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00064165:_____/14:10286842

Výsledek na webu

<a href="http://dx.doi.org/10.1177/1932296814533847" target="_blank" >http://dx.doi.org/10.1177/1932296814533847</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1177/1932296814533847" target="_blank" >10.1177/1932296814533847</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Glucose control in the ICU: Is there a time for more ambitious targets again?

Popis výsledku v původním jazyce

During the last 2 decades, the treatment of hyperglycemia in critically ill patients has become one of the most discussed topics in the intensive medicine field. The initial data suggesting significant benefit of normalization of blood glucose levels incritically ill patients using intensive intravenous insulin therapy have been challenged or even neglected by some later studies. At the moment, the need for glucose control in critically ill patients is generally accepted yet the target glucose values are still the subject of ongoing debates. In this review, we summarize the current data on the benefits and risks of tight glucose control in critically ill patients focusing on the novel technological approaches including continuous glucose monitoring and its combination with computer-based algorithms that might help to overcome some of the hurdles of tight glucose control. Since increased risk of hypoglycemia appears to be the major obstacle of tight glucose control, we try to put forwa

Název v anglickém jazyce

Glucose control in the ICU: Is there a time for more ambitious targets again?

Popis výsledku anglicky

During the last 2 decades, the treatment of hyperglycemia in critically ill patients has become one of the most discussed topics in the intensive medicine field. The initial data suggesting significant benefit of normalization of blood glucose levels incritically ill patients using intensive intravenous insulin therapy have been challenged or even neglected by some later studies. At the moment, the need for glucose control in critically ill patients is generally accepted yet the target glucose values are still the subject of ongoing debates. In this review, we summarize the current data on the benefits and risks of tight glucose control in critically ill patients focusing on the novel technological approaches including continuous glucose monitoring and its combination with computer-based algorithms that might help to overcome some of the hurdles of tight glucose control. Since increased risk of hypoglycemia appears to be the major obstacle of tight glucose control, we try to put forwa

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FP - Ostatní lékařské obory

OECD FORD obor

—

Projekt

—

Návaznosti

N - Vyzkumna aktivita podporovana z neverejnych zdroju

Rok uplatnění

2014

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Journal of diabetes science and technology

ISSN

1932-2968

e-ISSN

—

Svazek periodika

8

Číslo periodika v rámci svazku

4

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

6

Strana od-do

652-657

Kód UT WoS článku

—

EID výsledku v databázi Scopus

—